Literature DB >> 28265685

Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.

E E Abd El-Hakeem1, A M Kaki2, S A Almazlom2, A J Alsayyad3.   

Abstract

Delayed recovery from anesthesia remains a very challenging subject for anesthesiologists. This case report describes the clinical course of delayed recovery from neuromuscular blockade after laparoscopic partial nephrectomy in a patient on simvastatin. The patient was hypertensive on regular treatment with oral captopril 25 mg twice daily and amlodipine 5 mg once daily and hypercholesterolemic on regular simvastatin 40 mg once daily with a normal electrocardiogram (ECG). All preoperative laboratory findings were within normal ranges. The patient was premedicated with midazolam 1 mg and general anesthesia was induced with fentanyl 2 µg/kg body weight, propofol 2 mg/kg and rocuronium bromide 0.6 mg/kg to facilitate tracheal intubation. Anesthesia was maintained with inhalation of isoflurane 1.0-1.5 % in 40 % oxygen-enriched air and 25 µg boluses of fentanyl. The patient did not require any additional rocuronium throughout surgery which was finished after 4 h. The patient most probably had preoperative simvastatin-induced myotoxicity. This potentiated the muscle relaxant effect of rocuronium bromide and was the reason for patient unresponsiveness and delayed postoperative recovery. We can conclude that anesthesiologists should preoperatively identify statin myotoxicity and to avoid neuromuscular blocking drugs for statin-treated patients. Also, preoperative adjustment of statin dosage may be recommended.

Entities:  

Keywords:  Delayed recovery; General anesthesia; Hypercholesterolemia; Neuromuscular blockade; Simvastatin

Mesh:

Substances:

Year:  2017        PMID: 28265685     DOI: 10.1007/s00101-017-0284-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  26 in total

1.  Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.

Authors:  Bertrand Debaene; Benoît Plaud; Marie-Pierre Dilly; François Donati
Journal:  Anesthesiology       Date:  2003-05       Impact factor: 7.892

Review 2.  Is sugammadex economically viable for routine use.

Authors:  Thomas Fuchs-Buder; Claude Meistelman; Jan U Schreiber
Journal:  Curr Opin Anaesthesiol       Date:  2012-04       Impact factor: 2.706

3.  Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.

Authors:  D M Maybauer; G Geldner; M Blobner; F Pühringer; R Hofmockel; C Rex; H F Wulf; L Eberhart; C Arndt; M Eikermann
Journal:  Anaesthesia       Date:  2007-01       Impact factor: 6.955

4.  An assessment of statin safety by muscle experts.

Authors:  Paul D Thompson; Priscilla M Clarkson; Robert S Rosenson
Journal:  Am J Cardiol       Date:  2006-02-09       Impact factor: 2.778

5.  Residual Neuromuscular Blockade.

Authors:  Anna L Plummer-Roberts; Christina Trost; Shawn Collins; Ian Hewer
Journal:  AANA J       Date:  2016-02

6.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

Review 7.  Statin safety: an overview and assessment of the data--2005.

Authors:  Harold Bays
Journal:  Am J Cardiol       Date:  2006-02-08       Impact factor: 2.778

8.  Subclinical hypothyroidism: A cause for delayed recovery from anaesthesia?

Authors:  V Vijay Kumar; Padmanabha Kaimar
Journal:  Indian J Anaesth       Date:  2011-07

9.  Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.

Authors:  Martina Grosse-Sundrup; Justin P Henneman; Warren S Sandberg; Brian T Bateman; Jose Villa Uribe; Nicole Thuy Nguyen; Jesse M Ehrenfeld; Elizabeth A Martinez; Tobias Kurth; Matthias Eikermann
Journal:  BMJ       Date:  2012-10-15

Review 10.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25
View more
  1 in total

1.  Immune-Mediated Myopathy in a Patient Presenting for Melanoma Resection and Sentinel Lymph Node Biopsy.

Authors:  Allan R Escher; Jamie P Hoffman; Sarah Alfieri; Bruno Bordoni; Raymond M Evans
Journal:  Cureus       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.